Related references
Note: Only part of the references are listed.Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness
S. Thambiah et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Effects of Sevelamer on HbA1c, Inflammation, and Advanced Glycation End Products in Diabetic Kidney Disease
Helen Vlassara et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
Yves Sabbagh et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality
Victoria Shalhoub et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice
Igor G. Nikolov et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Low-dose fish oil supplementation increases serum adiponectin without affecting inflammatory markers in overweight subjects
Anders Gammelmark et al.
NUTRITION RESEARCH (2012)
Sclerostin and Dickkopf-1 in Renal Osteodystrophy
Daniel Cejka et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Sclerostin: Just One More Player in Renal Bone Disease?
Tilman B. Drueeke et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
Tamara Isakova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Single-Dose, Placebo-Controlled, Randomized Study of AMG 785, a Sclerostin Monoclonal Antibody
Desmond Padhi et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
The Amazing Osteocyte
Lynda F. Bonewald
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
FGF23 induces left ventricular hypertrophy
Christian Faul et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality
Myles Wolf et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
Tamara Isakova et al.
KIDNEY INTERNATIONAL (2011)
Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease
Tamara Isakova et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Sevelamer Decreases Systemic Inflammation in Parallel to a Reduction in Endotoxemia
A. E. M. Stinghen et al.
BLOOD PURIFICATION (2010)
Sclerostin: Current Knowledge and Future Perspectives
M. J. C. Moester et al.
CALCIFIED TISSUE INTERNATIONAL (2010)
Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
Rodrigo B. Oliveira et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Leptin Stimulates Fibroblast Growth Factor 23 Expression in Bone and Suppresses Renal 1α,25-Dihydroxyvitamin D3 Synthesis in Leptin-Deficient Mice
Kiyomi Tsuji et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis
Vijay K. Yadav et al.
NATURE MEDICINE (2010)
Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study
Vincent Matthias Brandenburg et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
Mariateresa Fulciniti et al.
BLOOD (2009)
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
The Pathogenesis of Vascular Calcification in the Chronic Kidney Disease Mineral Bone Disorder: The Links Between Bone and the Vasculature
Keith A. Hruska et al.
SEMINARS IN NEPHROLOGY (2009)
Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
Astrid Fahrleitner-Pammer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The mild to moderate kidney disease (MMKD) study
Danilo Fliser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease
A. Levin et al.
KIDNEY INTERNATIONAL (2007)
Convergence between bone and energy homeostases: Leptin regulation of bone mass
Gerard Karsenty
CELL METABOLISM (2006)
Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass
Frederic Morvan et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Definition, evaluation, and classification of renal osteodystrophy: A position statement from kidney disease: Improving global outcomes (KDIGO)
S. Moe et al.
KIDNEY INTERNATIONAL (2006)
Megestrol acetate in a moderate dose for the treatment of malnutrition-inflammation complex in maintenance dialysis patients
M Rammohan et al.
JOURNAL OF RENAL NUTRITION (2005)
The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?
HH Malluche et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes
MP Reilly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Arterial calcifications and bone histomorphometry in end-stage renal disease
GM London et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Review on uremic toxins:: Classification, concentration, and interindividual variability
R Vanholder et al.
KIDNEY INTERNATIONAL (2003)
Influence of leptin on arterial distensibility - A novel link between obesity and cardiovascular disease?
A Singhal et al.
CIRCULATION (2002)
Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS)
AM Wallace et al.
CIRCULATION (2001)
Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men
M Sato et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Share Paper
